Latest news with #Motiva
Yahoo
22-05-2025
- Entertainment
- Yahoo
The Only Nike Memorial Day Shoe Deals Worth Shopping Before They Sell Out
If you purchase an independently reviewed product or service through a link on our website, WWD may receive an affiliate commission. It's late May, which means three things: The sun's out, we're all feeling excited for summertime, and Memorial Day sales are kicking off early across your favorite footwear brands, including a not-to-miss secret sale at Nike. More from WWD The Best Memorial Day Home Deals to Shop Early This Week The Top 10 Designer Bags Deals From Nordstrom's Memorial Day Sale to Upgrade Your Summer Basics Lacoste and FP Movement Serve Tenniscore With an Exclusive New Sneaker Drop If you're a Swoosh-brand devotee like we are, you've likely already made a list of the best Nike shoes that deserve space on your shoe rack (but which you might not have had the time or energy to snag quite yet). Let this Memorial Day Nike sale shake you from your complacency, then, and serve as the perfect excuse to update your spring style ahead of hotter temperatures. This year, we're delighted to see the top Nike shoes under $100, like the 'It' girl–approved Cortez kicks, on sale for over 20 percent off — alongside editor-loved signature styles like the Motiva (Nike's first dedicated walking shoe release); chunky dad silhouettes such as the V2K Run; and Y2K-inspired ones the likes of the P-6000, all going for up to 39 percent off on the site. You already know that discounts this good won't stick around forever, so why not make today the day you treat your footwear rotation to Nike's top hits… for less? The styles we're highlighting in this roundup couldn't be a better fit for amping up your everyday ensembles this summer. After all, many of them fit squarely into that hot-for-2025 retro sneakers category (hi, color-happy Killshot 2!), making for an effortless way to level up all the 'fits in your warm-weather capsule wardrobe. Technical sneakers make their appearance here, too, in case you're planning on crushing more casual runs this season or have already begun training for a fall marathon. While some shoe brands might only put their less popular sneaker selections on sale during Memorial Day, there's nothing secondary about the Nike shoes witnessing markdowns as we speak. In fact, a lot of the on-sale picks are swathed in brand-new colorways or are relatively new arrivals on the Nike scene themselves: having been released, like the Pegasus 41 stepper, within the past year or so. Ready to turn heads during your upcoming summer vacation, while securing invaluable comfort, lightness, and stability with every step? Nike comes in clutch to provide all that and more, with early Memorial Day deals on its bestsellers. Because that's just the Nike way.$67.97 $90 24% off Buy Now at nike Only those who have been living under a rock don't yet know that the Nike Cortez sneaker is a legend and a half. Having received placement in 'Forrest Gump' and on the feet of Farah Fawcett, Dakota Johnson (who donned it on set last year in 'Baroque Brown'), Emily Ratajkowski, and beyond, the heritage kick gets continually updated to match the mood of the cultural moment at hand. This particular version sticks to the basics: with a cocoa-colored Swoosh symbol out of leather, wedge insert–boosted midsole, and outsole bedecked by Nike's iconic herringbone pattern. $67.97 $90 24% off buy now at nike $66.97 $110 39% off Buy Now at nike Despite what it might look like, there's nothing grandfatherly about the Nike P-6000. A ventilated mesh upper is made attractive with carefully placed leather panels (both real and synthetic); a rubber outsole is guaranteed to provide the pavement-gripping, responsive traction Nike's lifestyle and technical footwear is known for; and, as far as the shoe's roster of A-list wearers goes, it includes stars like Shay Mitchell, Suki Waterhouse, and Kylie Jenner, many of whom have found that the sneaker perfectly rounds out gym outfits. $82.97 $110 25% off Buy Now at nike $90.97 $120 24% off Buy Now at nike When WWD and FN's commerce director Adam Mansuroglu tested out the Nike Motiva walking shoe last fall, he was thrilled by the plush comfort and ease of movement it supplied through an exaggerated rocker, shock-absorbing Comfortgroove tech on the outsole, and a higher heel-to-toe drop that blesses high arches. The shoe, whose Premium version takes things up a notch by way of irresistible pastels, simply works. Based on the joint efforts of a widened toe box, a firm heel cup, and a soft foam collar, it's both roomy and capable of holding your foot in a stable position — whether you're racking up miles on the treadmill or your local boardwalk. $82.97 $110 25% off Buy Now at nike $112.97 $160 29% off Buy Now at nike Introduced in 2010 as a running sneaker, the Zoom Vomero 5 soon entered the sartorial lexicons of everyone (not just athletes) as a lifestyle sneaker capable of supporting wearers through errand runs, work trips, and even date nights if styled strategically. A richly layered upper gives a lot to look at, as plastic side caging provides a 'tucked-in' feeling and Air Zoom cushioning grants lift. $120.97 $160 24% off Buy Now at nike $98.97 $140 29% off Buy Now at nike Considering that the Pegasus 41 only dropped last summer, we're shocked by the fact that it's already marked down at Nike for close to 30 percent off. Now's your very best chance to indulge in the shoe's reengineered mesh that decreases weight and increases breathability, as well as the ReactX foam midsole that just might make you feel like you're flying. Peace of mind will come from the fact that it's partially made with materials sourced from post-consumer and post-manufactured waste. $98.97 $140 29% off Buy Now at nike $54.97 $90 39% off Buy Now at nike Nike's Court Legacy Lift shoe is endlessly wearable and able to match any outfit under the sun, including your best spring dresses. A platform midsole acts as a godsend for shorter girlies, while a padded heel and tongue keep feet secure and comfy all day long — no matter where your adventures take you. $55.97 $70 20% off Buy Now at nike $102.97 $120 14% off Buy Now at nike Everyone from Jennifer Lawrence and Mikey Madison to Dakota Johnson and Kaia Gerber love and frequently don their Nike V2K Run shoes. Why the hype? Metallic and plastic details on the upper are retro-futuristic to the max here, and a dual-density foam midsole makes the 'walking on clouds' cliché ring true. In other words, the style is a cool-girl magnet that also scores major points in functionality. $127.97 $150 15% off Buy Now at nike The Nike Shox R4 originally debuted in 2000, so it's really no wonder that it continues to reference (and revere) the early aughts aesthetic. This shoe's most applause-worthy feature is the Nike Shox cushioning: made up of four separate pillars on the heel that evenly distribute weight and help runners excel. You don't have to have the Strava app on your phone, though, to enjoy the benefits of the Shox R4's high-traction waffle outsole and superior ventilation. $67.97 $90 24% off Buy Now at nike The Killshot 2 has undeniable tenniscore influences, yet it's also a city shoe through and through: meant to help you apply the TikTok-viral 'wrong shoe' theory without sacrificing an ounce of street style in the process. The upper's suede and leather work together to bestow vintage character on the shoe; a gum rubber sole, meanwhile, pays dividends in durability. The pictured 'Stadium Green' colorway will make your favorite denim pop, and we also dare you to wear it with formal work attire. $111.97 $185 39% off Buy Now at nike Rolled out in the spring of 2024, the Air Max Plus Drift shoe is kept at peak freshness by Nike through regular colorway updates. One look at this style is enough to confirm its edgy grooviness, what with that gradient coloring and wavy lines. Practically speaking, its synthetic materials on the upper are interspersed with mesh that makes feet feel airy and cool even on the most humid days. A supportive arch pays homage to a whale's tail, and it's safe to say the sneaker has already made just as big of a splash in the past year. For more than 75 years, Footwear News has been the shoe authority. Our coverage spans top industry news, retail trends, head-to-toe fashion, athletic and outdoor analysis, and more. Footwear News' global network of editors has carefully curated all product selections featured using our expansive brand knowledge and thorough research to find quality, long-lasting items. Since 1910, WWD — often referred to as 'the fashion bible' — has been the leading industry voice of authority for senior executives in the global women's and men's fashion, retail and beauty communities, while also informing the consumer media that cover the market. Today, WWD's breaking news and trend coverage continues to be a trustworthy resource for both fashion insiders and consumers alike. Our shopping editors continue to uphold WWD's editorial standards and values with quality, expert-backed product selections. Learn more about us here. Stacia Datskovska is a Senior Commerce Writer at WWD and FN. Previously, she worked at ELLE DECOR as an assistant digital editor, covering all things luxury, culture, and lifestyle through a design lens. Her bylines over the past five years have appeared in USA Today, Baltimore Sun, Teen Vogue, Boston Globe, Food & Wine, and more. Prior to joining ELLE DECOR, Datskovska learned the ins and outs of e-commerce at Mashable, where she tested products, covered tentpole sales events, and curated gift guide roundups. She graduated from NYU with a bachelor's degree in journalism and international relations. Datskovska frequently covers not-to-miss footwear deals timed to major holidays, including those found in the Nike universe.
CNBC
16-05-2025
- Business
- CNBC
Aramco says it has U.S. tie-ups worth up to $90 billion amid Trump Gulf tour
Saudi Aramco said on Wednesday it had signed 34 preliminary deals with major U.S. companies, potentially worth up to $90 billion in a push to deepen commercial ties with the United States on the back of President Donald Trump's visit to the kingdom. The announcement was made a day after Riyadh pledged $600 billion in U.S. investments. Still, most tie-ups listed by the state oil giant were memorandums of understanding without a value attached. Some deals have also been previously announced, such as the agreement to buy 1.2 million tons of LNG per year for a 20-year term from NextDecade. The agreements underscore Saudi Arabia's efforts to strengthen its energy partnerships and attract foreign investment as it looks to balance oil dominance with broader industrial and technological growth under Vision 2030. "The U.S. is really a good place to put our investment," Aramco CEO Amin Nasser said on Tuesday at the U.S.-Saudi Investment Forum in Riyadh. The forum coincided with Trump's four-day tour of the Gulf, marked by lavish receptions and a series of business deals, including $142 billion in arms agreements. Aramco is the economic backbone of Saudi Arabia, generating a bulk of the kingdom's revenue through oil exports and funding its ambitious Vision 2030 diversification drive. Its shares have fallen almost 9% this year. The company said the agreements, struck through its Aramco Group Companies, aim to build on its longstanding ties with U.S. companies, enhance shareholder value, and expand collaboration in energy and other strategic sectors. A memorandum of understanding with tech heavyweight Nvidia aims to establish advanced industrial AI infrastructure, including an AI Hub, an engineering and robotics center, and workforce training programs. Aramco also signed an MoU with ExxonMobil to evaluate a significant upgrade to their SAMREF refinery, with plans to expand it into an integrated petrochemical complex. It also inked a non-binding agreement with Amazon Web Services to collaborate on digital transformation and lower-carbon initiatives, while an MoU with Qualcomm focuses on collaboration in enhancing industrial networks and AI capabilities. "Our U.S.-related activities have evolved over the decades, and now include multi-disciplinary R&D, the Motiva refinery in Port Arthur, start-up investments, potential collaborations in LNG, and ongoing procurement," Nasser said in a statement. Aramco said on Tuesday it would invest $3.4 billion to expand the Motiva refinery in Texas. Beyond energy, the state oil giant has become a key vehicle for industrial development, digital transformation, and foreign investment. It expanded existing relationships with several high-profile U.S. suppliers including SLB, Baker Hughes, GE Vernova and Honeywell. On the financial services front, it has forged agreements with asset management giants PIMCO, State Street Corporation and Wellington. It also signed a deal for short-term cash investments through a unified investment fund, named 'Fund of One', with financial heavyweights BlackRock, Goldman Sachs, Morgan Stanley and PIMCO.
Korea Herald
15-05-2025
- Business
- Korea Herald
Aramco signs up to $90b in US deals amid Trump Gulf tour
DUBAI, United Arab Emirates (Reuters) — Saudi Aramco said on Wednesday it had signed 34 preliminary deals with major US companies, potentially worth up to $90 billion in a push to deepen commercial ties with the United States on the back of President Donald Trump's visit to the kingdom. The announcement was made a day after Riyadh pledged $600 billion in US investments. Still, most tie-ups listed by the state oil giant were memorandums of understanding without a value attached. Some deals have also been previously announced, such as the agreement to buy 1.2 million tons of liquefied natural gas per year for a 20-year term from NextDecade. The agreements underscore Saudi Arabia's efforts to strengthen its energy partnerships and attract foreign investment as it looks to balance oil dominance with broader industrial and technological growth under Vision 2030. "The US is really a good place to put our investment," Aramco CEO Amin Nasser said on Tuesday at the US-Saudi Investment Forum in Riyadh. The forum coincided with Trump's four-day tour of the Gulf, marked by lavish receptions and a series of business deals, including $142 billion in arms agreements. Aramco is the economic backbone of Saudi Arabia, generating a bulk of the kingdom's revenue through oil exports and funding its ambitious Vision 2030 diversification drive. The company said the agreements, struck through its Aramco Group Companies, aim to build on its longstanding ties with US companies, enhance shareholder value, and expand collaboration in energy and other strategic sectors. A memorandum of understanding with tech heavyweight Nvidia aims to establish advanced industrial AI infrastructure, including an AI Hub, an engineering and robotics center, and workforce training programs. Aramco also signed an MoU with ExxonMobil to evaluate a significant upgrade to their SAMREF refinery, with plans to expand it into an integrated petrochemical complex. It also inked a non-binding agreement with Amazon Web Services to collaborate on digital transformation and lower-carbon initiatives, while an MoU with Qualcomm focuses on collaboration in enhancing industrial networks and AI capabilities. "Our US-related activities have evolved over the decades, and now include multi-disciplinary (research and development), the Motiva refinery in Port Arthur, start-up investments, potential collaborations in LNG, and ongoing procurement," Nasser said in a statement. Aramco said on Tuesday it would invest $3.4 billion to expand the Motiva refinery in Texas. Beyond energy, the state oil giant has become a key vehicle for industrial development, digital transformation and foreign investment. It expanded existing relationships with several high-profile US suppliers including SLB, Baker Hughes, GE Vernova and Honeywell. On the financial services front, it has forged agreements with asset management giants PIMCO, State Street Corporation and Wellington. It also signed a deal for short-term cash investments through a unified investment fund, named 'Fund of One,' with financial heavyweights BlackRock, Goldman Sachs, Morgan Stanley and PIMCO.
Time of India
13-05-2025
- Business
- Time of India
US crude oil climbs more than $1 on Saudi investment
U.S. crude oil futures climbed more than $1 a barrel on Tuesday as the White House announced Saudi Arabia's plans to invest $600 billion in the United States. Brent crude futures rose 88 cents, or about 1.35%, to $65.84 a barrel by 1417 GMT. U.S. West Texas Intermediate (WTI) crude was up $1.13, or about 1.82%, at $63.08. The two benchmarks rose by about 4% or more in the previous session after the U.S. and China agreed on sharp reductions to tariffs for at least 90 days, which also boosted Wall Street stocks and the dollar. U.S. President Donald Trump was visiting Saudi Arabia on Tuesday as part of a trip through the Middle East. The U.S. also unveiled a defense sale agreement with Saudi Arabia worth $142 billion. Live Events Part of the new Saudi investment will go to Saudi Aramco's Motiva refining and petrochemical complex in Port Arthur, Texas. The market is now evaluating the impact of the trade truce, said PVM analyst Tamas Varga. "Coupled with the scheduled steep increase in OPEC+ supply in May and June, the upside might prove limited." The Organization of the Petroleum Exporting Countries (OPEC) has raised oil output by more than previously expected since April, with May output likely to increase by 411,000 barrels per day. Meanwhile, sources told Reuters that Saudi Arabia's crude oil supply to China will hold steady in June after hitting its highest in more than a year in the previous month after an OPEC+ decision to increase output. It is the second-largest crude supplier to China behind Russia. Elsewhere, signs broadly point to demand for refined fuel remaining strong. "Despite the deteriorating outlook for crude demand, positive signals from the fuel markets cannot be overlooked," JPMorgan analysts said in a note. "Although international crude prices have declined by 22% since their peak on January 15, both refined product prices and refining margins have remained stable." Reduced refining capacity - mostly in the U.S. and Europe - is tightening gasoline and diesel balances, increasing reliance on imports and raising susceptibility to price spikes during maintenance and unplanned outages, they added.
Business Wire
07-05-2025
- Business
- Business Wire
Establishment Labs Reports First Quarter 2025 Financial Results
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the first quarter ended March 31, 2025. First Quarter Highlights and Outlook First quarter worldwide revenue of $41.4 million, including $6.2 million of Motiva sales in the United States. 2025 revenue guidance maintained at $205 million to $210 million, year over year growth of 23%–26%. First quarter gross margin of 67.2% compared to 65.6% in the year-ago period. First quarter loss from operations was $16.9 million compared to a loss of $8.8 million in the year-ago period. First quarter adjusted EBITDA loss of $12.1 million compared to a loss of $4.0 million in the year-ago period. First quarter cash use before financing was $21.0 million compared to use of $18.1 million in the year ago period. Cash balance of $69.2 million as of March 31, 2025. Peter Caldini appointed CEO effective May 7, 2025. Launched Preservé, the second offering in the company's minimally invasive platform. 'Our Motiva launch in the United States continues to be one of the fastest aesthetic launches in history,' said Peter Caldini, Chief Executive Officer. 'Our momentum is increasing, and our success in the United States is having a positive impact on our overall results. We should meaningfully exceed the $35 million US revenue guidance we provided in February and are on track to achieve positive EBITDA in 2025 and cash flow positive in 2026. As we continue to scale our business, improve execution, and find additional cost efficiencies globally, these improvements will be clear in our results.' First Quarter 2025 Financial Results Total revenue for the quarter ended March 31, 2025 was $41.4 million compared to $37.2 million for the same period in 2024. Gross profit for the first quarter was $27.8 million, or 67.2% of revenue, compared to $24.4 million, or 65.6% of revenue, for the same period in 2024. The increase in gross profit margin was primarily driven by geographic mix and higher average selling prices. Total operating expenses for the first quarter were $44.8 million, a increase of $11.6 million compared to $33.2 million in the first quarter of 2024. SG&A expenses for the first quarter increased approximately $10.8 million to $39.7 million compared to $28.9 million in the first quarter of 2024. The increase in SG&A was primarily the result of our increased investment in the United States including increases in personnel, commissions and marketing expenses. R&D expenses increased approximately $0.8 million to $5.1 million in the first quarter compared to $4.3 million for the same quarter a year ago. The increase was primarily due to increases in personnel costs. Net loss for the first quarter was $20.7 million compared to a net loss of $16.2 million in the year ago period. The Company's cash balance on March 31, 2025 was $69.2 million. Cash decreased $21.2 million from December 31, 2024, primarily as a result of operating losses. Conference Call and Webcast Information Establishment Labs will host a conference call and webcast today at 4:30 p.m. Eastern Time to discuss its financial results. The conference call can be accessed by dialing (877) 407-8037 (U.S. and Canada) or (201) 689-8037 (international) and using conference ID number 13750827. In addition, the live and archived webcast will be available in the Investor Relations section of the Company's website at About Establishment Labs Establishment Labs Holdings Inc. is a global medical device company dedicated to improving women's health and wellness in breast aesthetics and reconstruction through the power of science, engineering, and technology. The Company offers a portfolio of solutions for breast health, breast aesthetics, and breast reconstruction in over 90 countries. With over four million Motiva ® devices delivered to plastic and reconstructive surgeons since 2010, the Company's products have created a new standard for safety and patient satisfaction. The company's minimally invasive platform consists of Mia Femtech®, a unique minimally invasive experience for breast harmonization, and Preservé™, a breast tissue preserving and minimally invasive technology for breast augmentation, revision augmentation and mastopexy augmentation. GEM® is a next generation minimally invasive system for gluteal ergonomic modeling currently undergoing an IRB approved pivotal study. The Motiva Flora® tissue expander is used to improve outcomes in breast reconstruction following breast cancer and is the only regulatory-approved expander in the world with an integrated port using radio-frequency technology that is MRI conditional. Zensor™ is an RFID technology platform used to safely identify implantable devices from outside the body, and includes the company's first biosensor Zen°™, currently part of an IRB approved pivotal study to measure core breast temperature. These solutions are supported by over 200 patent applications in 20 separate patent families worldwide and over 100 scientific and clinical studies and publications in peer reviewed journals. Establishment Labs manufactures at two facilities in Costa Rica compliant with all applicable regulatory standards under ISO13485:2024 and FDA 21 CFR 820. Please visit our website for additional information at Non-GAAP Financial Measures To supplement our financial results presented in accordance with GAAP, this release includes the following measures defined by the Securities and Exchange Commission as non-GAAP financial measures: EBITDA and Adjusted EBITDA. These non-GAAP measures are not based on any comprehensive set of accounting rules or principles and should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and may be different from non-GAAP measures used by other companies, limiting the usefulness of the measures for comparison with other companies. EBITDA is defined as net income or loss excluding: (1) interest income and expense; (2) provision for income taxes; and (3) depreciation and amortization. We consider EBITDA useful to an investor in evaluating and facilitating comparisons of our operating performance between periods by removing the impact of our capital structure (primarily interest expense) and asset base (primarily depreciation and amortization) from our operating results. We also present Adjusted EBITDA which includes additional adjustments for items such as other non-cash charges, gains or losses on extinguishment of debt, share-based compensation, contract termination costs, and foreign currency gains and losses. We believe that Adjusted EBITDA provides useful supplemental information to investors regarding our ongoing operating performance that, when considered with net income and EBITDA, is beneficial to an investor's understanding of our performance. We believe disclosure of this information is also useful to investors as it provides insight into the earnings that management uses to make strategic decisions. These non-GAAP financial measures should be considered along with, but not as alternatives to, net income or loss as prescribed by GAAP as a measure of our operating performance. EBITDA and Adjusted EBITDA do not represent cash generated from operating activities under GAAP and should not be considered as alternatives to cash flows from operations or any other operating performance measure prescribed by GAAP. These measures are not measures of our liquidity, nor are indicative of funds available to fund our cash needs. These measurements do not reflect cash expenditures for long-term assets and other items that have been and will be incurred. EBITDA and Adjusted EBITDA may include funds that may not be available for management's discretionary use due to functional requirements to conserve funds for capital expenditures, property acquisitions, and other commitments and uncertainties. Please see 'Reconciliation of EBITDA and Adjusted EBITDA' for a reconciliation of these measures to net income (loss), the most directly comparable financial measure. This release also includes information about our expectations regarding Adjusted EBITDA on a forward-looking basis. We have not provided a reconciliation of such forward-looking Adjusted EBITDA information because a reconciliation of such measure to our expected GAAP net income (loss) on a forward-looking basis is not available without unreasonable efforts. The timing or amount of various reconciling items that would impact the forward-looking expectations for this non-GAAP financial measure are uncertain, depend on various factors and cannot be reasonably predicted. Such unavailable information could be material to our results computed in accordance with U.S. GAAP. Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the 'Exchange Act'). You can find many (but not all) of these statements by looking for words such as 'approximates,' 'believes,' 'expects,' 'anticipates,' 'estimates,' 'intends,' 'plans,' 'intends to,' 'would,' 'will,' 'may' or other similar expressions in this press release. Any statements that refer to projections of our future financial or operating performance, anticipated trends in our business, our goals, strategies, focus and plans, including related product development and commercialization and regulatory approvals, and other characterizations of future events or circumstances, including statements expressing general optimism about future operating results, related to the company's performance are forward-looking statements. We claim the protection of the safe harbor contained in the Private Securities Litigation Reform Act of 1995. We caution investors that any forward-looking statements presented in this report, or that we may make orally or in writing from time to time, are expressions of our beliefs and expectations based on currently available information at the time such statements are made. Such statements are based on assumptions, and the actual outcome will be affected by known and unknown risks, trends, uncertainties, and factors that are beyond our control. Although we believe that our assumptions are reasonable, we cannot guarantee future performance, and some will inevitably prove to be incorrect. As a result, our actual future results and the timing of events may differ from our expectations, and those differences may be material. Factors, among others, that could cause actual results and events to differ materially from those described in any forward-looking statements include risks and uncertainties relating to: our ability to successfully, timely and cost-effectively develop, seek and obtain regulatory clearance for and commercialize our product offerings; the rate of adoption of our products by healthcare providers or other customers; the success of our marketing initiatives; the safe and effective use of our products; our ability to protect our intellectual property; our future expansion plans and capital allocation; our ability to expand upon and/or secure sources of credit or capital; our ability to develop and maintain relationships with qualified suppliers to avoid a significant interruption in our supply chains; our ability to attract and retain key personnel; our ability to scale our operations to meet market demands; the effect on our business of existing and new regulatory requirements; and other economic and competitive factors. These and other factors that could cause or contribute to actual results differing materially from our expectations include, among others, those risks and uncertainties discussed in the company's annual report on Form 10-K filed on February 28, 2025 and will be discussed in the company's quarterly report on Form 10-Q that will be filed on May 9, 2025, which risks and uncertainties may be updated in the future in other filings made by the company with the Securities and Exchange Commission. The risks included in those documents are not exhaustive, and additional factors could adversely affect our business and financial performance. We operate in a very competitive and rapidly changing environment. New risk factors emerge from time to time, and it is not possible for us to predict all such risk factors, nor can we assess the impact of all such risk factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. We are not undertaking any obligation to update any forward-looking statements. Accordingly, investors should use caution in relying on past forward-looking statements, which are based on known results and trends at the time they are made, to anticipate future results or trends. ESTABLISHMENT LABS HOLDINGS INC. Consolidated Balance Sheets (In thousands) March 31, 2025 December 31, 2024 (Unaudited) Assets Current assets: Cash and cash equivalents $ 69,178 $ 90,347 Accounts receivable, net of allowance for credit losses of $5,031 and $3,088 63,236 65,002 Inventory, net 90,425 78,766 Prepaid expenses and other current assets 8,857 8,922 Total current assets 231,696 243,037 Long-term assets: Property and equipment, net of accumulated depreciation 76,390 78,028 Goodwill 1,209 1,209 Intangible assets, net of accumulated amortization 11,566 11,683 Right-of-use operating lease assets, net 5,192 5,561 Other non-current assets 7,311 7,313 Total assets $ 333,364 $ 346,831 Liabilities and shareholders' equity Current liabilities: Accounts payable $ 45,188 $ 44,760 Accrued liabilities 20,604 16,536 Other liabilities, short-term 3,246 6,982 Total current liabilities 69,038 68,278 Long-term liabilities: Note payable, net of debt discount and issuance costs 220,340 219,577 Operating lease liabilities, non-current 3,803 4,203 Other liabilities, long-term 1,633 1,678 Total liabilities 294,814 293,736 Shareholders' equity: Total shareholders' equity 38,550 53,095 Total liabilities and shareholders' equity $ 333,364 $ 346,831 Expand
